The drugmaker Amgen Inc. has agreed to pay Massachusetts General Hospital $186 million to settle a dispute over royalties the hospital was paid for its role in helping develop Enbrel, a drug used to treat rheumatoid arthritis and psoriasis. The one-time payment will free Amgen from obligations to pay future royalties from North American sales of Enbrel, the hospital said in a news release Tuesday.
June 08, 2006 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
The drugmaker Amgen Inc. has agreed to pay Massachusetts General Hospital $186 million to settle a dispute over royalties the hospital was paid for its role in helping develop Enbrel, a drug used to treat rheumatoid arthritis and psoriasis.
The one-time payment will free Amgen from obligations to pay future royalties from North American sales of Enbrel, the hospital said in a news release Tuesday after the settlement was reported in The Boston Globe.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
Health Law Associate CT Shipman is seeking an associate to join our national longstanding health law practice. Candidates must have t...
Shipman & Goodwin LLP is seeking two associates to expand our national commercial real estate lending practice. Candidates should have ...
Duane Morris LLP has an immediate opening for a senior level, highly motivated litigation associate to join its dynamic and growing Employme...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
